• 2022-06-06
    Vaccination for this hepatic disease is with viral surface antigen and usually provides immunity.
    A: Hepatitis A
    B: Hepatitis B
    C: Hepatitis C
    D: Hepatitis D
    E: Hepatitis E
  • B

    内容

    • 0

      Assuming<br/>that a vaccine against hepatitis C was developed. To evaluate the<br/>effectiveness of this vaccine, the population that should be<br/>selected as the research object is ( ) A: People<br/>with low incidence of hepatitis C B: People infected with hepatitis C C: People<br/>who have been infected with hepatitis B D: High-risk population of hepatitis C

    • 1

      The reduction of liver dullness can be seen in A: Acute hepatitis B: Liver abscess C: Acute hepatic necrosis D: Hepatic cyst E: Liver cancer

    • 2

      What is the most likely diagnosis of this specimen?[img=979x589]1803a0373c900cd.jpg[/img] A: hepatitis A B: cirrhosis complicated with hepatocellular carcinoma C: hepatitis B D: hepatocellular steatosis

    • 3

      Which of the following is NOT the basic pathological changes of chronic viral hepatitis() A: Inflammation B: Cirrhosis C: Fibrosis D: Cell apotosis

    • 4

      Which of the following is not a main clinical manifestation of acute viral hepatitis? A: Loss of appetite B: Fatigue C: In some cases jaundice D: Hepatomegaly and liver function impairment E: Emaciation